Meet GOLD’s new catalyst – CSL Behring’s Karen Pinachyan - European Medical Journal

Meet GOLD’s new catalyst – CSL Behring’s Karen Pinachyan

EMJ GOLD
Karen Pinachyan
Series 5: episode 6

In this week’s episode, Isabel and Jade share some snippets from the interview with GOLD’s next catalyst Karen Pinachyan, Head of Medical Affairs, Europe, CSL Behring.

In this teaser edition of the full interview, Karen shares his motivation for joining the pharmaceutical industry, his thoughts on how to shift the care paradigm towards personalised medicine and how he believes both industry and healthcare systems can work together to deliver more value to patients.

A little more on GOLD’s guest…

Karen Pinachyan is Head of Medical Affairs, Europe, CSL Behring. Here, he works across five therapeutic areas: immunology, haematology, respiratory, cardiometabolic and transplantation. Prior to joining the industry, Karen worked as a physician in France, but he left his medical career behind in a bid to impact more lives on a larger scale. He has spent time at both Roche and Boehringer Ingelheim, gaining a wealth of experience in medical affairs and clinical development along the way. In his role at CSL Behring, he is passionate about putting patients first and translating science into business value.

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.